The term duct of Luschka is ambiguous, as it may refer to supravesicular [2] [3] or subvesicular ducts. [4] [5] Supravesicular ducts are typically in the gallbladder bed. A 2012 review suggested that ...
Learn more about a new treatment for biliary tract cancers with high levels of HER2. The drug zanidatamab has been approved by the FDA, thanks to a clinical trial co-led by MSK.
Background: The purpose of the present study was to define the differential diagnostic markers of benign and malignant bile duct strictures without demonstrable mass on ultrasonography (US ...
The FDA has approved a new drug, zanidatamab, for adults with advanced biliary tract cancer, or BTC. Marketed under the brand name Ziihera, it is a first-of-a-kind treatment for patients with ...
Cholangiocarcinoma is classically described as an irregular narrowing of the bile duct with shouldered scalloped margins. The stricture usually causes a high-grade or complete obstruction with ...
Zanidatamab-hrii received FDA accelerated approval for HER2-positive biliary tract cancer, showing a 52% objective response rate in the HERIZON-BTC-01 trial. Biliary tract cancers represent 3% of ...
Results from a blood test may indicate an infection or inflammation in the gallbladder, bile ducts, pancreas, or even the liver. Imaging tests can help identify gallstones in your gallbladder.
Biliary tract cancer occurs in the bile ducts and gallbladder, with approximately 23,000 diagnoses in the US each year. Life expectancy is poor, with just 5% to 15% of patients expected to live ...